• Calpeptin in Translational Research: Mechanistic Insights &

  2026-06-02

  This thought-leadership article explores Calpeptin’s unique role as a nanomolar calpain inhibitor in fibrosis and inflammation studies. We examine the mechanistic rationale for targeting calpain, highlight recent evidence—including extracellular vesicle inhibition in cancer—and provide actionable strategic guidance for translational researchers. The discussion integrates insights from APExBIO's Calpeptin and contextualizes its impact within the evolving competitive and experimental landscape.

• Strategic mRNA Isolation: Mechanistic Insights for Translati

  2026-06-02

  Explore how APExBIO Oligo (dT) 25 Beads drive precision mRNA isolation, bridging advanced mechanistic biology with strategic guidance for translational scientists. This article uniquely integrates biological rationale, validation, competitive analysis, and future-facing perspectives, informed by current research and best practices.

• Cy3 NHS ester (non-sulfonated): Practical Labeling Workflows

  2026-06-01

  Cy3 NHS ester (non-sulfonated) enables sensitive fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides, especially where organic co-solvents like DMSO or DMF can be tolerated. It is not suitable for workflows requiring water-only solubility or for applications demanding long-term storage of dye solutions. This article details practical use, protocol parameters, and troubleshooting for reliable integration into biomedical imaging and quantitative labeling experiments.

• Honokiol Triggers Paraptosis in APL via mTOR and MAPK Activa

  2026-06-01

  This study demonstrates that honokiol induces paraptosis-like, non-apoptotic cell death in acute promyelocytic leukemia (APL) by activating mTOR and MAPK signaling pathways. The findings reveal a distinct, caspase-independent mechanism involving endoplasmic reticulum stress and proteasome inhibition, offering new insights for targeting apoptosis-resistant leukemia.

• Filipin III: Applied Cholesterol Detection in Membrane Biolo

  2026-05-31

  Filipin III, a polyene macrolide antibiotic, sets the benchmark for visualizing cholesterol-rich membrane microdomains with unmatched specificity. This guide delivers stepwise experimental workflows, practical troubleshooting, and insights from recent immunometabolic research, empowering scientists to maximize data quality in cholesterol detection assays.

• Ganetespib (STA-9090): Advanced Hsp90 Inhibition in Cancer R

  2026-05-30

  Ganetespib (STA-9090) stands out as a potent, selective Hsp90 inhibitor, enabling precise disruption of chaperone networks in preclinical cancer studies. This article delivers actionable workflows, comparative insights, and troubleshooting strategies to unlock robust antitumor data using APExBIO’s trusted Ganetespib reagent.

• O-propargyl-puromycin (OPP): Precision Protein Synthesis in

  2026-05-29

  O-propargyl-puromycin (OPP) enables high-resolution, quantitative mapping of nascent protein synthesis in live cells, transforming workflows in immunology and cell biology. This article details advanced applications, robust experimental protocols, and troubleshooting strategies for maximizing data quality with OPP, drawing on the latest mechanistic insights linking translation, mitochondrial function, and antibody production.

• Gepotidacin in Uncomplicated Gonorrhea: Efficacy and Study I

  2026-05-29

  The referenced phase 2 clinical study presents gepotidacin, a novel bacterial topoisomerase inhibitor, as a highly effective oral treatment for uncomplicated urogenital gonorrhea, achieving microbiological cure rates of ≥95%. This work addresses the urgent challenge of multidrug-resistant Neisseria gonorrhoeae, demonstrating both mechanistic novelty and promising clinical potential.

• Glioma Organoids with Preserved Microenvironment for Drug Te

  2026-05-28

  This study introduces a glioma organoid model that retains the tumor microenvironment, including immune components, from patient-derived tissue. The approach enables more physiologically relevant drug screening and therapeutic evaluation, opening new avenues for personalized treatment strategies.

• Gap26 Connexin 43 Mimetic Peptide: Redefining Pain Pathway R

  2026-05-28

  Explore how Gap26, a potent connexin 43 mimetic peptide, unlocks new advances in neurobiology and pain mechanism research. This article reveals underappreciated mechanistic insights and protocol refinements that distinguish it from standard guides.

• Cy3 NHS Ester (Non-Sulfonated): Protocols and Best Practices

  2026-05-27

  Cy3 NHS ester (non-sulfonated) provides robust, high-sensitivity fluorescent labeling of proteins, peptides, and oligonucleotides, especially where water-insoluble dyes are compatible with the target biomolecule. This dye is best suited for workflows tolerant of organic co-solvents and is not recommended for labeling delicate proteins sensitive to DMSO or DMF.

• Fluorouracil: Optimized Protocols & Troubleshooting in Solid

  2026-05-27

  Fluorouracil (5-Fluorouracil, Adrucil) enables reproducible, high-impact workflows for colon and breast cancer models, with APExBIO providing robust purity and solubility. This guide translates advanced research, including multidrug resistance insights, into actionable protocols and troubleshooting strategies for solid tumor investigations.

• Sodium Dicloxacillin Monohydrate in Advanced MSSA Research

  2026-05-26

  Sodium dicloxacillin monohydrate empowers researchers to interrogate the inhibition of methicillin-sensitive Staphylococcus aureus (MSSA) across both intra- and extracellular environments. This guide details optimized protocols, key innovations, and troubleshooting strategies that maximize data quality in Gram-positive bacterial infection research.

• AO/PI Double Staining Kit: Precision Cell Viability Assays

  2026-05-26

  The AO/PI Double Staining Kit empowers researchers with rapid, multiplexed discrimination of viable, apoptotic, and necrotic cells in complex models. Its dual-dye approach streamlines apoptosis and necrosis detection for advanced workflows, particularly in organoid and cancer research.

• ML385 and NRF2 Inhibition: Expanding Beyond Oncology Researc

  2026-05-25

  Explore ML385 as a selective NRF2 inhibitor, with in-depth analysis of its molecular action, advanced applications, and unique insights into inflammatory bone disease research. This article delivers a deeper, cross-disciplinary perspective on NRF2 signaling pathway inhibition.

11785 records 1/786 page Next 12345 下5页 Last page